Overview

Study of Fluoxetine in Adults With Autistic Disorder

Status:
Completed
Trial end date:
2005-08-01
Target enrollment:
Participant gender:
Summary
This is a study to determine the effect of fluoxetine in the treatment of adult autism and on functional ability and behavior associated with autism. Evidence suggests abnormal serotonin function in autism. Fluoxetine is a selective inhibitor of the serotonin transporter.
Phase:
N/A
Details
Lead Sponsor:
Icahn School of Medicine at Mount Sinai
Treatments:
Fluoxetine